Index of reports
> Hospitalization (837)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 837 Next >>
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: female
Reactions: Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2007-11-15
End date: 2008-10-01
Pegasys
Indication: Hepatitis C
Start date: 2007-11-15
End date: 2008-10-01
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female, weighing 83.0 kg (182.6 pounds)
Reactions: Tongue Ulceration, Thermoanaesthesia, Rash Pruritic, Oral Discomfort, Fatigue, Cough, Vomiting, Nausea, Haemorrhoids, Hypoaesthesia, Cognitive Disorder, Aptyalism, Anal Fissure, Anxiety, Throat Irritation, Diarrhoea, Dehydration, Insomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-27
End date: 2012-08-04
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
Start date: 2012-07-27
End date: 2012-08-04
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-27
End date: 2012-08-04
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 81.6 kg (179.6 pounds)
Reactions: Fatigue, Dizziness, Vision Blurred, Feeling Abnormal, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Start date: 2012-08-12
Ribavirin
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-14
End date: 2012-08-12
Ribavirin
Dosage: unk
Administration route: Oral
Start date: 2012-08-12
Pegasys
Dosage: 180 unk, unk
Start date: 2012-08-12
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
Start date: 2012-07-14
End date: 2012-08-03
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-14
End date: 2012-08-10
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-27
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Occult Blood, Anaemia, Faeces Discoloured
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2009-02-01
End date: 2009-04-07
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2008-08-01
End date: 2009-04-07
Other drugs received by patient: Sirolimus
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Rash, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-21
Ribavirin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-05-22
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-21
End date: 2012-04-03
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-27
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-17
Ribavirin
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-04-23
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-15
Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: , weighing 117.9 kg (259.4 pounds)
Reactions: Abscess Rupture, Peritonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-08-01
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Start date: 2012-01-20
End date: 2012-05-18
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-05-18
Pegasys
Dosage: 180 a?g, unk
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-05-18
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-08-27
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Swelling Face, Neutropenia, Rash Pruritic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-01
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 90.7 kg (199.5 pounds)
Reactions: Fatigue, Wrist Fracture, Diarrhoea, Liver Function Test Abnormal, Anaemia, Haemorrhoids, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Hepatitis C
End date: 2012-07-01
VX-950
Dosage: unk
Administration route: Oral
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-01
End date: 2011-10-01
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
End date: 2012-07-01
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: HIP Arthroplasty
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simvastatin
Simvastatin
Ribavirin
Simvastatin
Blinded Narlaprevir
Simvastatin
Blinded Boceprevir
Simvastatin
Simvastatin
Peginterferon Alfa-2B
Placebo
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-23
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-23
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
Start date: 2012-07-23
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-27
Patient:
Reactions: Breast Pain, Viral Load Increased, Varicose Vein Ruptured, Drug Ineffective, Pyrexia, Hypoaesthesia, Gynaecomastia, Malaise, Overdose, Swelling, Alopecia, Oedema Peripheral, Sensitivity of Teeth, Fluid Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: unk, bid
Administration route: Oral
Start date: 2012-04-01
End date: 2012-06-18
Victrelis
Dosage: unk, tid
Administration route: Oral
Start date: 2012-04-01
End date: 2012-06-18
Ribavirin
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-01-01
End date: 2005-01-01
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-18
End date: 2012-04-01
Ribavirin
Dosage: unk
Administration route: Oral
Start date: 2011-12-01
End date: 2012-04-01
Other drugs received by patient: Coumadin; Coumadin; Pegasys; Lansoprazole; Pegasys; Pegasys
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-25
Patient: female
Reactions: Cholelithiasis, Weight Decreased, Peroneal Nerve Palsy, Fear, Transfusion, Asthenia, Myocardial Infarction, Blood Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2011-09-16
Pegasys
Indication: Hepatitis C
Start date: 2011-09-16
End date: 2012-06-27
Victrelis
Indication: Hepatitis C
End date: 2012-06-27
Ribavirin
End date: 2012-06-27
Possible Ribavirin side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 54 year old female
Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-22
End date: 2012-05-08
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-28
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-06-12
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-19
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-20
End date: 2012-07-31
Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female, weighing 65.8 kg (144.8 pounds)
Reactions: Nausea, Haemorrhoids, Headache, Rash, Tremor, Loss of Consciousness, Dysgeusia, Haematochezia, Fatigue, Malaise, RED Blood Cell Count Decreased, Blood Potassium Decreased, Diarrhoea, Insomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Telaprevir
Dosage: 375 mg 2 tablets tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-30
End date: 2012-07-27
Pegasys
Indication: Hepatitis C
Start date: 2012-04-30
Ribavirin
Dosage: divided doses
Indication: Hepatitis C
Start date: 2012-04-30
Other drugs received by patient: Cymbalta; Zofran; Vitamin D; Lisinopril; Omeprazole; Lasix; Trazodone Hydrochloride
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: male
Reactions: Hepatitis, Liver Transplant
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
End date: 2006-01-01
Interferon
Indication: Hepatitis C
End date: 2006-01-01
Possible Ribavirin side effects in female
Reported by a pharmacist from United States on 2012-08-24
Patient: female
Reactions: Incoherent, RED Blood Cell Count Decreased, Faecal Incontinence, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 90 mcg qw sq
Indication: Hepatitis C
Start date: 2012-05-30
Ribavirin
Dosage: 400mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-30
Other drugs received by patient: Incivek
Possible Ribavirin side effects in
Reported by a physician from Argentina on 2012-08-24
Patient:
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Placebo
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Peginterferon Alfa-2B
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Ribavirin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
PEG-Intron
Dosage: 150 units
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-06
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Blinded Boceprevir
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-13
Ribavirin
Dosage: 2400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-15
End date: 2011-01-12
Simvastatin
Dosage: 2400 mg, unk
Administration route: Oral
Start date: 2010-07-15
End date: 2011-01-13
Possible Ribavirin side effects in 67 year old male
Reported by a pharmacist from United States on 2012-08-24
Patient: 67 year old male
Reactions: Drug Level Below Therapeutic, Anaemia, Deep Vein Thrombosis, Haematoma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Telaprevir
Dosage: 750mg, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-05
Ribavirin
Dosage: 600 mg, bid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-05
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-24
Patient:
Reactions: Intestinal Polyp, Gastrointestinal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Telaprevir
Dosage: 750 mg, q8h
Administration route: Oral
Norvasc
PEG-Intron
Dosage: unk, qw
Indication: Hepatitis C
Start date: 2012-02-16
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Other drugs received by patient: Centrum (Minerals (Unspecified) (+) Vitamins (Unspecified)); Xanthophyll
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-08-24
Patient: male
Reactions: Post Procedural Complication
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180mcg q week sq
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-10
Ribavirin
Dosage: 1000mg daily po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-10
Possible Ribavirin side effects in
Reported by a physician from Brazil on 2012-08-23
Patient:
Reactions: Apparent Death, Panic Attack, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: unk, bid
Administration route: Oral
Indication: Hepatitis
Start date: 2012-06-01
Victrelis
Dosage: unk, tid
Administration route: Oral
Indication: Hepatitis
Start date: 2012-05-01
End date: 2012-06-01
Other drugs received by patient: Interferon (Unspecified)
Possible Ribavirin side effects in
Reported by a physician from Germany on 2012-08-23
Patient:
Reactions: Facial Paresis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
Simvastatin
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
Blinded MK-5172
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
Simvastatin
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
PEG-Intron
Dosage: 0.5 ml, qw
Indication: Hepatitis C
Start date: 2011-12-13
End date: 2012-07-27
Peginterferon Alfa-2B
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
Rebetol
Dosage: 3 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
End date: 2012-07-30
Blinded Therapy
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-09
Placebo
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
Ribavirin
Dosage: 1 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-12
Other drugs received by patient: Amlodipine; Acetaminophen
Possible Ribavirin side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Mass, Sepsis, Glomerulonephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: 1000 mg, qd
Indication: Influenza Like Illness
Start date: 2011-11-15
Boceprevir
Dosage: 2400 mg, qd
Indication: Hepatitis C
Start date: 2011-12-13
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2011-11-15
Peginterferon Alfa-2B
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2011-11-15
Truvada
Dosage: 1 df, qod
Indication: HIV Infection
Start date: 2007-01-23
Other drugs received by patient: Norvir; Sertraline Hydrochloride; Plavix; Tamsulosin Hydrochloride; Crestor; Levocarnil; Crestor; Neorecormon; Dexeryl Tablets; Reyataz
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Blood Glucose Decreased, RED Blood Cell Count Decreased, Insomnia, Blood Glucose Fluctuation, DRY Skin, Decreased Appetite, Skin Fissures
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 microgram, qw
Indication: Chronic Hepatitis
Start date: 2011-10-07
Victrelis
Dosage: 4 df, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-11
Ribavirin
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2011-10-07
Other drugs received by patient: Insulin
Possible Ribavirin side effects in
Reported by a physician from Poland on 2012-08-23
Patient:
Reactions: Lymphadenopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-07-29
Viread
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-05-18
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-29
Lopinavir and Ritonavir
Dosage: 2 df, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2010-05-18
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-07-01
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-07-29
Peginterferon Alfa-2B
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2010-07-01
Epivir
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-05-18
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-07-29
Other drugs received by patient: Bebetina; Bebetina; Bebetina; Bebetina
Possible Ribavirin side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23
Patient: 50 year old male
Reactions: Abdominal Discomfort, Malaise
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-05-24
End date: 2012-06-06
Ribavirin
Dosage: 600 unk, unk
Administration route: Oral
Start date: 2012-06-07
End date: 2012-07-19
VX-950
Dosage: unk
Administration route: Oral
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-03-08
End date: 2012-03-13
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-14
End date: 2012-05-01
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-03-07
Peginterferon Alfa-2B
Dosage: 1.5 a?g/kg, unk
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-07-12
VX-950
Dosage: 2250 mg, qd
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-03-06
VX-950
Dosage: 1500 mg, qd
Start date: 2012-03-07
End date: 2012-04-26
Ribavirin
Dosage: 600 unk, unk
Administration route: Oral
Start date: 2012-05-02
End date: 2012-05-23
Possible Ribavirin side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-09
End date: 2010-03-02
Peginterferon Alfa-2B
Dosage: 120 mcg, qw
Indication: Hepatitis C
Start date: 2010-02-09
End date: 2010-03-08
Other drugs received by patient: Metoprolol Tartrate; Aciphex; Ascorbic Acid (+) Folic Acid (+) Vitamin B Complex; Lipitor; Synthroid
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-08-23
Patient:
Reactions: Mass, Acute Respiratory Distress Syndrome, Glomerulonephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2011-11-15
Boceprevir
Dosage: 2400 mg, qd
Indication: Hepatitis C
Start date: 2011-12-13
End date: 2012-07-28
Peginterferon Alfa-2B
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2011-11-15
End date: 2012-07-28
Acetaminophen
Dosage: 1000 mg, qd
Indication: Influenza Like Illness
Start date: 2011-11-15
Truvada
Dosage: 1 df, qod
Indication: HIV Infection
Start date: 2007-01-23
Other drugs received by patient: Reyataz; Crestor; Levocarnil; Neorecormon; Sertraline Hydrochloride; Tamsulosin Hydrochloride; Plavix; Norvir; Crestor; Dexeryl Tablets
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: unk, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
PEG-Intron
Dosage: unk, qw
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Page 1 Next >>
|